Growth Metrics

Elevance Health (ELV) Return on Capital Employed (2016 - 2025)

Elevance Health (ELV) has disclosed Return on Capital Employed for 17 consecutive years, with 0.0% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 8.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 8.0% decrease, with the full-year FY2024 number at 0.03%, changed 0.0% from a year prior.
  • Return on Capital Employed was 0.0% for Q3 2025 at Elevance Health, up from 0.43% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.48% in Q2 2024 to a low of 1.33% in Q2 2023.
  • A 5-year average of 0.48% and a median of 0.41% in 2025 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 182bps in 2024, then tumbled -91bps in 2025.
  • Elevance Health's Return on Capital Employed stood at 1.06% in 2021, then skyrocketed by 31bps to 0.73% in 2022, then surged by 74bps to 0.19% in 2023, then plummeted by -84bps to 0.35% in 2024, then soared by 100bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for ELV's Return on Capital Employed are 0.0% (Q3 2025), 0.43% (Q2 2025), and 0.35% (Q1 2025).